Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Endo Int'l Plc First Floor Minerva House Simmonscourt Road Ballsbridge Dublin L2 19355 IRL

P: 011-353-1268

Description:

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.

Key Statistics

Overview:

Market Capitalization, $K 995,547
Shares Outstanding, K 226,776
Annual Sales, $ 2,947 M
Annual Net Income, $ -1,031,470 K
Last Quarter Sales, $ 729,430 K
Last Quarter Net Income, $ -79,420 K
60-Month Beta 1.43
% of Insider Shareholders 1.50%
% of Institutional Shareholders 97.05%
Float, K 223,374
% Float 98.50%

Growth:

1-Year Return -60.84%
3-Year Return -72.61%
5-Year Return -93.99%
5-Year Revenue Growth 12.62%
5-Year Earnings Growth -39.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.60 on 11/04/19
Next Earnings Date 11/05/19
Earnings Per Share ttm 2.40
EPS Growth vs. Prev Qtr 15.38%
EPS Growth vs. Prev Year -15.49%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ENDP Ratios

Ratio
Price/Earnings ttm 1.92
Price/Earnings forward 6.66
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -99.08
Return-on-Assets (Before Tax) 5.58
Profit Margin % -35.00
Net Margin % 12.13
Debt/Equity N/A
Price/Sales 0.36
Price/Cash Flow 0.74
Price/Book N/A
Book Value/Share -2.92
Interest Coverage -0.80
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar